US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 18, 2017 (10 years ago)

Nystatin Oral Suspension

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

What was recalled

Nystatin Oral Suspension, USP 100,000 units per mL, a) 2 fl. oz. (60 mL), 24 bottles per case (NDC 66689-008-02), b) 16 fl. oz. (237 mL), 12 bottles per case (NDC 66689-008-16), Rx only, Manufactured by VistaPharm, Largo, FL 33771

Recalling firm
VistaPharm, Inc.
NDC code
66689-008-02
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0457-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Nystatin recalls

See all
Class II · Moderate risk Ongoing

Nystatin Cream USP

Reason Subpotent Drug: Low out of specification assay results performed during long-term stability testing.

Padagis US LLC NDC 45802-059-35 D-0677-2026
Class II · Moderate risk Ongoing

Nystatin 150 Mu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-1 D-0157-2024
Class II · Moderate risk Ongoing

Nystatin 2 Bu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-4 D-0156-2024
Class II · Moderate risk Ongoing

Nystatin 500 Mu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-3 D-0155-2024
Class II · Moderate risk Ongoing

Nystatin 5bu

Reason Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.

Fagron, Inc NDC 51552-0041-5 D-0154-2024